Abstract

BackgroundOvarian tissue cryopreservation has a wide range of cancerous indications. Avoiding relapse becomes a specific concern that clinicians frequently encounter. The data about the comparative viability of cancer cells after cryopreservation are limited. This study aimed to evaluate the effect of cryopreservation on breast cancer cells.MethodsWe used in-vitro cultured ZR-75-1 and MDA-MB-231 cell lines. Cell samples of each lineage were distributed into the non-intervened and cryopreserved groups. The cryopreservation procedures comprised programmed slow freezing followed by thawing at 100 °C, 60 s. Biological phenotypes and the related protein markers were compared between the two groups. The EVOS FL Auto 2 Cell Image System was used to monitor cell morphology. Cell proliferation, motility, and penetration were characterized by CCK-8, wound-healing, and transmembrane assay, respectively. The expression of Ki-67, P53, GATA3, E-cadherin, Vimentin, and F-Actin was captured by immunofluorescent staining and western blotting as the proxy measurements of the related properties. The chorioallantoic membrane (CAM) xenotransplantation was conducted to explore angiogenesis induced by cancer cells.ResultsAfter 5 days in vitro culture, the cell concentration of cryopreserved and non-intervened groups was 15.7 × 104 vs. 14.4 × 104cells/ml, (ZR-75-1, p > 0.05), and 25.1 × 104 vs. 26.6 × 104 cells/ml (MDA-MB-231, p > 0.05). Some cryopreserved ZR-75-1 cells presented spindle shape with filopodia and lamellipodia and dissociated from the cell cluster after cryopreservation. Both cell lines demonstrated increased cell migrating capability and invasion after cryopreservation. The expression of Ki-67 and P53 did not differ between the cryopreserved and non-intervened groups. E-cadherin and GATA3 expression downregulated in the cryopreserved ZR-75-1 cells. Vimentin and F-actin exhibited an upregulated level in cryopreserved ZR-75-1 and MDA-MB-231 cells. The cryopreserved MDA-MB-231 cells induced significant angiogenesis around the grafts on CAM with the vascular density 0.313 ± 0.03 and 0.342 ± 0.04, compared with that of non-intervened cells of 0.238 ± 0.05 and 0.244 ± 0.03, p < 0.0001.ConclusionsCryopreservation promotes breast cancer cells in terms of epithelial-mesenchymal transition and angiogenesis induction, thus increasing metastasis risk.

Highlights

  • Ovarian tissue cryopreservation has a wide range of cancerous indications

  • This study aimed to evaluate the effect of cryopreservation on human breast cancer cells in the form of compacted fragments

  • Cell proliferation is invariable after cryopreservation After 5 days of in vitro culture, the ZR-75-1 cell concentration of the cryopreserved and non-intervened groups was 15.7 × 104 cells/ml and 14.4 × 104 cells/ml, respectively, p > 0.05

Read more

Summary

Introduction

Ovarian tissue cryopreservation has a wide range of cancerous indications. Avoiding relapse becomes a specific concern that clinicians frequently encounter. The data about the comparative viability of cancer cells after cryopreservation are limited. This study aimed to evaluate the effect of cryopreservation on breast cancer cells. With the aim of fertility preservation, ovarian tissue cryopreservation (OTC) is currently the medical treatment of an increasing application [1]. Clinicians concern about the existence of disseminated cancer cells that are dormant in the ovaries before anti-cancer treatment [3]. Data about effect of cryopreservation on viability of cancer cells are limited. The activity of xenobiotic metabolizing enzymes and responsiveness to enzyme-inducing agents reduced in cryopreserved human hepatocytes compared with that in freshly isolated cells [5]. Endothelial progenitor cells derived from UCB-MNCs induced responses to cytokines and recovery of carotid artery injury analogous with those from peripheral blood of healthy volunteers [7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call